Reliability and validity of Patient Reported Outcome Information System (PROMIS) physical function, pain interference, and fatigue as patient reported outcome measures in adult idiopathic inflammatory myopathies: International study from the OMERACT myositis working group
Authors' conclusion
This study presents test-retest reliability and construct validity evidence supporting PROMIS Pain Interference (6a v1.0), Fatigue (7a v1.0), and Physical Function (8b v2.0) using a large international cohort of patients with IIM. Internal consistency of these instruments was excellent. A ceiling effect was noted in the Pain Interference instrument.
Study context
- Population
- Adult idiopathic inflammatory myopathies (IIM) patients from OMERACT Myositis Working Group international clinic sitessurveys sent
- Participants
- 368 patients
- Comparison
- PROMIS Pain Interference 6av1.0 vs PROMIS Fatigue 7av1.0 vs PROMIS Physical Function 8bv2.0
- Outcome
- Construct validity (Pearson correlations vs a priori hypotheses) and test-retest reliability (intraclass correlation coefficient) of PROMIS instruments
- Follow-up
- Time zero and 7 days
Methodological detailsinternational, multicentre, online surveys (2019, 2021), a priori hypotheses (>75% Myositis Working Group (MWG) agreement)
- International
- Multicentre
- Online surveys (2019, 2021)
- A priori hypotheses (>75% MWG agreement)
Performance
As reported in the abstract
Construct validity: a priori hypotheses met
A priori hypotheses met, all PROMIS instruments
10 out of 13
Pain Interference hypotheses met
3 of 4
Fatigue hypotheses met
4 of 4
Physical Function hypotheses met
3 of 5
Further findings
Internal consistency (Cronbach's α)
- Excellent internal consistency for all PROMIS instruments
Ceiling and floor effects
- No ceiling or floor effects except a ceiling effect in Pain Interference
Original publication
Reliability and validity of PROMIS physical function, pain interference, and fatigue as patient reported outcome measures in adult idiopathic inflammatory myopathies: International study from the OMERACT myositis working group. Semin Arthritis Rheum. Published 3 November 2022. doi:10. 1016/ j. semarthrit. 2022. 152111
Composed by AI from the published abstract and checked against it. How Briefs are made →